Jimma University College of Medicine and Health Science, School of Nursing, Jimma, Ethiopia.
University of Gondar, College of Medicine and Health Science, School of Nursing, Gondar, Ethiopia.
J Infect Public Health. 2019 Nov-Dec;12(6):873-877. doi: 10.1016/j.jiph.2019.05.018. Epub 2019 Jun 15.
Due to the increasing availability of antiretroviral treatment, HIV infected children are living longer which points out the necessity of disclosure. And which is important to support the uptake and adherence to treatment. Disclosure is an important measure to prevent secondary transmission when children are sexually active.
The aim of this study was to determine the prevalence of HIV positive status disclosure and associated factors among human immune virus-infected children in pediatric antiretroviral treatment clinics in Gondar town public health facilities.
An institution based cross-sectional study was conducted among 449 primary caregivers of children aged 6-15years in regular follow-up at pediatric ART clinics in Gondar town public health facilities between March 3, 2018, to April 25, 2018. All subjects in the study area were included in the study. Data was collected in 5 pediatric ART clinics in Gondar town by structured questionnaires through face to face interview and supplemented by chart review to obtain some clinical factors. The variables which have an association with disclosure were identified on the basis of AOR, with 95%CI and p-value <0. 05. Model fitness was checked using Hosmer and Lemeshow goodness of fit test.
Out of 449 participants, 418 were interviewed with response rate of 93%. The prevalence of HIV positive status disclosure found to be 44%. Age of child >10years [AOR=5.88, (95% CI: 3.52, 9.81)], duration on ART [AOR=2.67 (95% CI: 1.59, 4.51)], place of follow-up [AOR=2.23 (95% CI: 1.27, 5.01)] and educational status of caregiver [AOR=3.00 (95% CI: 1.62, 5.56)] were identified variables.
The prevalence of disclosure found to be low. Therefore appropriate measure should be taken to promote disclosure.
由于抗逆转录病毒治疗的可及性不断提高,感染艾滋病毒的儿童寿命更长,这就指出了披露的必要性。这对于支持儿童接受和坚持治疗非常重要。当儿童具有性活跃性时,披露是预防二次传播的重要措施。
本研究旨在确定在贡德尔镇公共卫生设施的儿科抗逆转录病毒治疗诊所中,感染人类免疫病毒的儿童中艾滋病毒阳性状况披露的流行率及相关因素。
这是一项在 2018 年 3 月 3 日至 2018 年 4 月 25 日期间,在贡德尔镇公共卫生设施的儿科抗逆转录病毒治疗诊所接受常规随访的 449 名 6-15 岁儿童的主要照顾者中进行的基于机构的横断面研究。研究区域内的所有研究对象均纳入研究。通过面对面访谈,使用结构化问卷在 5 家儿科抗逆转录病毒治疗诊所收集数据,并通过病历回顾补充获取一些临床因素。根据比值比(AOR)、95%置信区间(CI)和 p 值<0.05,确定与披露相关的变量。使用 Hosmer 和 Lemeshow 拟合优度检验检查模型拟合度。
在 449 名参与者中,有 418 名接受了访谈,应答率为 93%。发现艾滋病毒阳性状况披露的流行率为 44%。儿童年龄>10 岁(AOR=5.88,95%CI:3.52-9.81)、抗逆转录病毒治疗时间(AOR=2.67,95%CI:1.59-4.51)、随访地点(AOR=2.23,95%CI:1.27-5.01)和照顾者的教育程度(AOR=3.00,95%CI:1.62-5.56)是确定的变量。
发现披露的流行率较低。因此,应采取适当措施促进披露。